Share on StockTwits

Shares of Sabra Health Care REIT (NASDAQ:SBRA) have been given a consensus rating of “Hold” by the eight ratings firms that are covering the company, Analyst RN reports. One investment analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $31.60.

Sabra Health Care REIT (NASDAQ:SBRA) traded down 0.73% during mid-day trading on Monday, hitting $28.60. 154,419 shares of the company’s stock traded hands. Sabra Health Care REIT has a 1-year low of $21.55 and a 1-year high of $32.40. The stock’s 50-day moving average is $29.28 and its 200-day moving average is $27.56. The company has a market cap of $1.121 billion and a price-to-earnings ratio of 164.63.

Sabra Health Care REIT (NASDAQ:SBRA) last released its earnings data on Monday, May 5th. The company reported $0.55 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.54 by $0.01. The company had revenue of $40.85 million for the quarter, compared to the consensus estimate of $35.75 million. During the same quarter last year, the company posted $0.47 earnings per share. Analysts expect that Sabra Health Care REIT will post $2.27 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Friday, May 30th. Stockholders of record on Thursday, May 15th will be given a dividend of $0.38 per share. This represents a $1.52 dividend on an annualized basis and a yield of 5.28%. The ex-dividend date of this dividend is Tuesday, May 13th. This is a boost from Sabra Health Care REIT’s previous quarterly dividend of $0.36.

A number of research firms have recently commented on SBRA. Analysts at Bank of America initiated coverage on shares of Sabra Health Care REIT in a research note on Monday. They set a “neutral” rating and a $29.00 price target on the stock. Separately, analysts at Raymond James reiterated an “outperform” rating on shares of Sabra Health Care REIT in a research note on Thursday, May 8th. They now have a $32.00 price target on the stock, up previously from $31.00. Finally, analysts at TheStreet downgraded shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating in a research note on Thursday, May 8th.

Sabra Health Care REIT, Inc (NASDAQ:SBRA) as a wholly owned subsidiary of Sun Healthcare Group, Inc, a provider of nursing, rehabilitative and related specialty healthcare services to the senior population in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.